IntroDuctIon
Ca 2 + -triggered exocytosis occurs in a number of biological processes such as neurotransmission 1, 2 , peptide release from neuroendocrine cells 3, 4 and granular secretion from mast cells 5 . In the case of neurotransmission, fusion events between synaptic vesicles and the active zone in the presynaptic membrane are tightly controlled by protein-protein and protein-membrane interactions involving soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), synaptotagmin, complexin, Munc18, Munc13 and other proteins 2, [6] [7] [8] [9] [10] [11] . The role of these and other proteins have been subject to intense investigations and controversies. In vitro assays have an important role in uncovering the molecular mechanism of synaptic vesicle fusion, as they allow manipulations and observations that are not possible in vivo.
In vitro ensemble assays with reconstituted proteoliposomes have been widely used to study SNARE-mediated membrane fusion 12 . Clearly, these early assays were important to establish that SNAREs have fusogenic activity. However, nearly all of these studies monitored lipid mixing only, defined as the exchange of lipids between membranes, rather than content mixing. Despite the ease of such ensemble lipid-mixing assays, they are subject to numerous pitfalls. Most notably, monitoring lipid mixing alone can be misleading, as lipid mixing can occur without or with markedly delayed content mixing (i.e., the exchange or release of aqueous content). For example, neuronal SNAREs alone do not produce much content mixing, although they readily induce lipid mixing 13, 14 , influenza virus-induced fusion content mixing occurs many seconds after initial lipid mixing 15 , and content mixing occurs several minutes after lipid mixing in vacuolar fusion 16 . Moreover, when membrane fusion is induced by DNA zippering, even inner leaflet mixing can occur without complete fusion 17 , although this will require verification with synaptic protein-induced fusion. We recently found an even more striking difference between content mixing and lipid mixing for Ca 2 + -triggered fusion with synaptic proteins 18 .
Content mixing measurements have been notoriously difficult to achieve for ensemble-based assays because of a number of technical hurdles, including potential leakiness of proteoliposomes, aggregation and vesicle rupture that can plague ensemble experiments. Such phenomena may produce a large fluorescence intensity change that may not be directly related to genuine fusion. Another issue with commonly used lipid-mixing ensemble experiments is that they cannot distinguish between docking and hemifusion (or fusion), as the observed lipid-mixing signal depends on both processes 19 . On a different note, some of the first ensemble lipidmixing studies used an unreasonably high protein-to-lipid ratio (e.g., 1:10 for synaptobrevin-reconstituted vesicles 12 ); this is a concern because high protein concentrations are known to cause vesicle instabilities. Finally, ensemble measurements may obscure heterogeneous fusion pathways, as they only observe averages rather than individual fusion events. This is indeed a problem for ensemble experiments, because single-vesicle lipid-mixing experiments revealed multiple intermediates in SNARE-mediated fusion 20, 21 , and our recent single vesicle-vesicle content and lipid-mixing experiments showed the existence of multiple fusion pathways for Ca 2 + -triggered fusion with synaptic proteins 18 .
Single-vesicle microscopy approaches can overcome these problems with ensemble assays. However, many in vitro studies of SNARE-mediated fusion with proteoliposomes at the singlevesicle level, have used only lipid-mixing indicators. For example, a tethered vesicle assay monitored fluorescence resonance energy transfer (FRET) between fluorescent lipids in donor and acceptor dye-containing vesicles, respectively 20, 22 . In a different single-vesicle assay, fluorescent lipids in synaptobrevin vesicles were used in order to observe the docking and fusion events on brushed supported lipid bilayers with reconstituted syntaxin/SNAP- 25 (refs. 21,23) .
to resolve two distinct lipid-mixing events that would correspond to outer and inner leaflet mixing of a single interacting vesicle pair, respectively 14 ; furthermore, there is the above-mentioned possibility of inner leaflet mixing without simultaneous content mixing. It is thus essential to use robust and reliable content mixing assays to study biological membrane fusion.
By using the soluble content marker calcein, we observed only very rare fusion between neuronal SNARE-only-containing vesicles and supported bilayers in our early studies 13 ; another group reported mostly vesicle bursting with this content marker, indicating that this particular soluble dye may have destabilized their particular vesicles 24 . More recently, relatively large content indicators (much larger than typical neurotransmitter molecules, such as glutamate) consisting of DNA hairpins were used for a tethered single-vesicle assay 25, 26 .
Our recent single vesicle-vesicle assay 14 uses the small watersoluble dye sulforhodamine B in order to monitor content mixing. It is important to note that this fluorophore did not destabilize our proteoliposomes, which mimic physiological lipid compositions and protein densities (protein-to-lipid ratios) 14 . We also monitored the state of the membrane with the lipid dye 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate (DiD), and the arrival of Ca 2 + in the evanescent field with Cascade Blue dye. Our assay simultaneously monitors the temporal sequence of content release and lipid mixing of individual vesicle pairs on a sub-100-millisecond time scale (Figs. 1-4) .
Our single vesicle-vesicle system starts from a metastable state of docked vesicle pairs that is established by incubation periods at zero Ca 2 + concentration 14 . The incubation periods at zero Ca 2 + are followed by Ca 2 + injection at a defined concentration. Our system thus mimics the arrival of a stepwise Ca 2 + concentration increase that acts on the readily releasable pool of primed synaptic vesicles. This stepwise Ca 2 + concentration increase is reminiscent of photolysis of caged Ca 2 + experiments in neurons that are typically also carried out at ambient temperature (25 °C) 27, 28 . In principle, our system is suitable for studies at other temperatures as well, although the stability of the vesicles need to be carefully checked at elevated temperature. Furthermore, our system should be extendable to a different Ca 2 + delivery method in order to mimic transient Ca 2 + concentration increases that are typical for physiological neurotransmitter release. On a different note, our incubation period at zero Ca 2 + should reduce cis-interactions between the C2 domains of synaptotagmin and its own membrane, which might otherwise prevent proper trans-interactions with acceptor vesicles in assays that use a constant nonzero Ca 2 + concentration 29 .
Optical tweezer pulling experiments recently revealed a partially folded intermediate of the SNARE complex under external force conditions 30 . This intermediate is likely to facilitate the metastable state of interacting, but mostly unfused, vesicles during the incubation periods at zero Ca 2 + in our assay. Indeed, during the incubation periods, we observed the formation of parallel trans SNARE complex interactions at the N-terminal ends of the SNARE complex 14 . Previous work from our laboratory showed that only a relatively small fraction (one-fifth) of reconstituted SNAREs form stable antiparallel configurations when they juxtapose membranes 13 ; this should not be confused with the observation that soluble SNARE fragments (i.e., not reconstituted into membranes) can form a much larger fraction of unstable antiparallel complexes in addition to the stable parallel SNARE complex 31 . Thus, we conclude that the majority of trans SNARE complexes are in a parallel, partially folded conformation in the metastable starting state of our single vesicle-vesicle system.
We observed that the majority of interacting vesicles formed hemifusion-free point contacts after the incubation periods, although a major fraction had undergone hemifusion with reconstituted fulllength neuronal SNAREs and synaptotagmin 1 (ref. 18) . Only a small (Fig. 4) .
Here we describe the detailed protocol for our original single vesicle-vesicle fusion system. However, recent improvements and modifications 18 are also briefly mentioned.
Comparison with other methods
There are a number of advantages of our single vesicle-vesicle microscopy system compared with all other single-vesicle assays known to us ( Table 1) . The unique features of our system are as follows:
Triggering of fusion processes by Ca 2 + or other factors. To our knowledge, our single vesicle-vesicle system is, to date, the only one that starts from a metastable state of interacting vesicles that have been incubated at zero Ca 2 + , mimicking primed synaptic vesicles before an action potential. Monitoring of the arrival of the Ca 2 + buffer in the evanescent field by using a third spectrally distinct dye. By using this approach, we showed that the rise time of the time-dependent content mixing probability upon Ca 2 + injection is faster than 100 ms (ref. 14) . One can therefore use the first occurrence of any content mixing event upon Ca 2 + injection as an indicator for the arrival of Ca 2 + in the evanescent field, as we did in our most recent work 18 . Of course, at a substantially faster time resolution, this simplified approach to determine Ca 2 + arrival in the evanescent field needs to be reconfirmed.
• •
The ability of buffer exchange during the incubation periods, and immediately before or after the fusion process. This feature of our system allows one to introduce accessory proteins or regulators at different stages. It should be noted, however, that the content or lipid dye fluorescence intensities of the donor vesicles should be checked before and after buffer exchange in order to ensure that vesicles did not get dislodged. In our experiments, we did not observe disruption of interacting vesicles upon buffer exchange. 
Applications of the method
We applied our single vesicle-vesicle microscopy system to mimic synaptic vesicle fusion with a minimal set of proteins: neuronal SNAREs, synaptotagmin 1 and complexin. Full-length constructs were used for all proteins. Upon Ca 2 + injection, we observed a fast fusion burst with a rise time faster than 100 ms (refs. 14,18) . In contrast, neuronal SNAREs alone produced only a lipid-mixing burst upon Ca 2 + injection, but with little content mixing; the effect of Ca 2 + in this SNARE-only case is probably caused by l-α-phosphatidylinositol-4,5-bisphosphate (PIP 2 ) that we added to the acceptor vesicle membranes 32 . This example illustrates the importance of monitoring content mixing, as lipid mixing can occur well before, or without, content mixing.
Our assay allows one to exchange buffer (e.g., change in Ca 2 + concentration) and the addition of other synaptic factors without disrupting interacting vesicle pairs. Thus, our assay allows one to perform manipulations that are not easily achievable in vivo.
Limitations
In our initial studies, we applied a relatively high Ca 2 + concentration in order to test our system under a variety of conditions 14 . This was a reasonable strategy at an early stage of technique development and proof-of-principle studies. After improvements in optical instrumentation use of a different surface preparation 26 , as well as in protein expression and purification 18 , we have recently been able to routinely perform experiments at 250-500 µM Ca 2 + , which is close to the physiological concentration range (starting at 10 µM and saturating at 100 µM) 33 , and is comparable to other recent in vitro experiments 34, 35 .
For the single-vesicle lipid-mixing experiments (i.e., no content mixing monitoring) by Lee et al. 22 , with reconstituted SNAREs and synaptotagmin 1, markedly higher PIP 2 and synaptotagmin concentrations were used compared with those in our experiments. Specifically, Lee et al. 22 used 6 mol% PIP 2 ; in contrast, we used 3.5 mol% in our experiments, consistent with measurements of PIP 2 in the plasma membrane of PC12 cells 36 . Furthermore, Lee et al. 22 used a 1:1 molar ratio of synaptotagmin to synaptobrevin with a protein-to-lipid ratio of 1:200 for reconstitution into liposomes; in contrast, we used a 1:4.6 molar ratio of synaptotagmin to synaptobrevin with a synaptobrevin protein-to-lipid ratio of 1:200 in our reconstitution protocol, consistent with observations of purified synaptic vesicles 37 . Furthermore, Lee et al. 22 performed experiments on mixtures of donor and acceptor vesicles in solution at a constant Ca 2 + concentration, rather than starting from the metastable state of interacting vesicle pairs at zero Ca 2 + as we did in our assay. Perhaps the particular conditions Lee et al. 22 used, as well as the possibility of synaptotagmin C2 cis-interactions with its own membrane when Ca 2 + is present before docking of vesicles, caused the paradoxical decrease of Ca 2 + -triggered lipid mixing from 10 to 100 µM, assuming background level at 100 µM.
Our initial studies 14 did not allow us to determine the initial state (docked, hemifused or fused) of individual vesicle pairs for the following reasons. First, in order to perform several experiments in parallel on the same coverslip consisting of multiple channels (Fig. 3) , we moved the microscope stage between data collection on individual channels. Our microscope stage was not precise enough to correlate the spots after the stage had been moved. Second, the lipid dye fluorescence intensity of the vesicles showed variation as a result of differences in vesicle size and dye concentration in individual vesicles. Thus, the absolute lipid dye fluorescence intensity is not necessarily indicative of the particular initial state of the interacting vesicles.
To determine the initial state of individual vesicle pairs before Ca 2 + injection, we recently performed entire experiments (imaging of the vesicles immediately upon addition of donor vesicles to the tethered acceptor vesicles, incubation, Ca 2 + injection, and observation) without moving the stage and switching the connecting tubes 18 . This alternative method allowed us to image the fluorescence intensities of both the content and lipid dyes immediately after mixing donor and acceptor vesicles, and then again just before Ca 2 + injection, thereby enabling the determination of any change in membrane state during the incubation period. However, as this method does not allow rapid switching between channels, multiple experiments had to be performed sequentially rather than in parallel, thus increasing the total amount of time required for the experiments. We are working on further improvements and automation to routinely enable monitoring of the initial state of the individual vesicle pairs at the time of Ca 2 + injection. The minimum time binning that we were able to achieve with our original setup 14 was 200 ms, effectively allowing the determination of rise and decay times of > 100 ms. The limited time resolution of that particular setup was due to a poor signal-to-noise ratio of the fluorescence intensity time traces when we used time bins shorter than 200 ms, even though the charge-coupled device (CCD) camera that we used is capable of a time resolution of 30 ms. The poor signal-to-noise ratio in turn was related to the low laser power that we used to minimize photobleaching, along with the large number of optical elements in the fluorescence emission paths (Fig. 2) . We are currently exploring simplifications of the optical apparatus in order to improve the time resolution for our assay; preliminary experiments enabled us to achieve 60-ms time binning.
During the observation period, we sometimes observed slow drifts of the content or lipid dye fluorescence intensities. Photobleaching is the most likely explanation for such drifts. For example, in Figure 4b , the lipid dye fluorescence intensity (red, upper line) slightly increases after the Ca 2 + injection (time point zero), and then gradually decreases. In Figure 4a , the content dye fluorescence intensity (green line) gradually increases over the observation period after Ca 2 + injection. These gradual fluorescence intensity increases are related to the reduction of dye self-quenching by photobleaching. Initially, this will cause a slight increase in fluorescence intensity. At some point, photobleaching will dominate and then the fluorescence intensity will gradually decrease. Ultimately, it is photobleaching that limits the useful time for continuous observation.
Experimental design
Protein expression and purification protocols for full-length synaptobrevin 2 (simply referred to as synaptobrevin), syntaxin 1A (simply referred to as syntaxin), SNAP-25A (simply referred to as SNAP-25), synaptotagmin 1 and complexin 1 (simply referred to as complexin) have been described in detail elsewhere 14, 18 . Marked improvements in the protocols for syntaxin, synaptobrevin, SNAP-25 and complexin have also been described elsewhere 18 . We simply refer to the purified samples as 'purified synaptobrevin solution' , 'purified syntaxin solution' and so on (see Materials).
We reconstituted proteins into acceptor (syntaxin/SNAP-25) and donor (synaptobrevin/synaptotagmin 1) vesicles with a detergent depletion method as previously described 14 and as detailed below. The homogeneity of reconstituted donor and acceptor vesicles obtained from this protocol was confirmed with cryo-electron microscopy, light scattering, single-molecule counting experiments to determine the protein number distributions in single vesicles, SDS gel electrophoresis of reconstituted vesicles and determination of the orientation of reconstituted proteins as previously described 14 .
We immobilized full-length syntaxin and SNAP-25 reconstituted acceptor vesicles on a PEG-containing surface via biotinneutravidin tethers (Fig. 1a) as detailed below. We added donor vesicles reconstituted with full-length synaptobrevin and synaptotagmin 1 to a sample chamber along with other factors, such as complexin (Fig. 1a) , as detailed below. We found that nonspecific binding of donor vesicles was very rare in our particular surface preparation, but it should be tested for each new experimental setup by incubating the acceptor-free surface with donor vesicles (Fig. 5) .
The content and lipid dyes were at sufficiently high concentrations in order to promote self-quenching of the fluorescence. We determined the optimum concentration of the dyes in order to achieve maximum sensitivity upon fusion (i.e., doubling of surface area or volume) by testing fluorescence intensities at various concentrations. We found that the optimum concentrations for the content dye sulforhodamine B and the lipid dye DiD were 50 mM and 3.5 mol%, respectively, for our system. We observed very little (less than 0.01%) bursting or vesicle leaking, suggesting that the imbalance created by the aqueous content dyes does not pose problems for our particular vesicles with their lipid composition and protein-to-lipid reconstitution ratios 14 .
A first quick (seconds) incubation period followed, wherein vesicles were allowed to interact via protein-protein interactions (Fig. 1b) . We then removed excess donor vesicles by extensive buffer washing. We observed faint fluorescence spots in the field of view originating from the self-quenched lipid dyes of docked donor vesicles. With a defined incubation time and acceptor vesicle concentration, we were able to compare the interaction efficiency of donor and acceptor vesicles for different experiments by simply counting the number of spots, indicating donor vesicles interacting with acceptor vesicles. We then incubated donor-acceptor vesicle pairs for a 30-min period at a zero-Ca 2 + concentration in order to maximize the population of vesicles that were ready for Ca 2 + -triggered fusion (Fig. 1c) . We observed that a shorter second incubation period decreased the number of vesicle pairs undergoing Ca 2 + -triggered fusion. The second incubation period may mimic priming of synaptic vesicles in the active zone. Other factors not yet present in our system may make this process faster in vivo.
We then connected the outlet of the flow chamber to a motorized syringe pump with a fixed flow rate in order to perform buffer exchange. Several seconds before Ca 2 + injection, we began to simultaneously monitor the fluorescence intensities from both the content and lipid dyes, as well as the blue dye that is part of the injected Ca 2 + buffer. We continued monitoring, typically for 30-50 s after Ca 2 + injection (Fig. 1d) . We collected the fluorescence emissions from the three dyes through an objective lens and projected them onto two electron multiplying charge-coupled device (EM-CCD) cameras. One camera simultaneously recorded both content and lipid dye fluorescence intensities using a dichroic beam splitter, whereas a second camera monitored the blue dye fluorescence intensity upon Ca 2 + buffer injection. One of the cameras was externally triggered by the other camera in order to allow simultaneous recording of all three fluorescence emissions. We then carried out analysis of the individual fluorescence intensity time traces.
Because a single slide can accommodate twelve chambers, control experiments can be easily performed with the same slide.
For example, four different experimental conditions could be tested in three channels with a single slide. For sufficient statistics, it is recommended that several hundred traces be analyzed that show fusion events; typically, this requires more than three channels and two slides for a particular setup and experimental conditions. EQUIPMENT SETUP Objective-based TIR fluorescence microscopy apparatus Our three-color custom-built, objective-based TIR fluorescence microscopy apparatus used a Nikon TE2000U inverted microscope (Nikon) (Fig. 2) . We combined laser excitation paths for content- and lipid-mixing dyes (Excelsior 532 nm, Spectra-Physics, Newport; cube 640 nm, Coherent) and for the Ca 2 + indicator dye (405 nm, Coherent) with dichroic mirrors. We expanded the laser beams by a telescope and then focused them to the back focal plane of the objective lens (Nikon Apo TIR ×100, 1.49 numerical aperture (NA)) by a converging lens with a focal length of 300 mm; they were then delivered to the interface between the cover glass and the sample chamber for TIR. We collected fluorescence emissions by the same objective lens and projected them to two EM-CCD cameras (iXon EM + DU-897, Andor Technology). We imaged the fluorescence emissions from sulforhodamine B and DiD with FF01-562/40 (Semrock) and HQ700/75m (Chroma Technology) optical band-pass filters, respectively, with one of the two CCD cameras. We imaged the fluorescence emission from the Cascade Blue separately using an optical band-pass filter (FF01-417/60, Semrock) with the second CCD camera. Attachment of tubes to outlet ports We attached a tube to the outlet port of the flow chamber by decorating the end of the tube with a small rubber O-ring (inner diameter (i.d.) 3/64 inch, outer diameter (o.d.) 9/64 inch) that was just large enough to cover the outlet ports on the slide (Fig. 3) . We glued an O-ring (yellow arrow) to a ferrule (Upchurch Scientific, part no. P-250) tightly locked on the 1/16-inch-o.d. tubing with a stainless steel lock ring. We used a custom-machined thin metal clamp to hold the ferrule-tube-O-ring assembly to the outlet port.
MaterIals

REAGENTS
proceDure Glass surface preparation and peG coating • tIMInG ~5 h  crItIcal This procedure can be performed using a similar protocol that has been published elsewhere 26 along with an instructional movie available at http://bio.physics.illinois.edu/movies/PEG%20protocol/. Test the surface preparation and PEG coating for non-specific binding (Fig. 5) .
The surface coverage can be tested by immobilizing DiD-labeled acceptor vesicles and imaging the vesicles.
| Place cover glasses in a staining rack and immerse the rack in acetone by holding it with Nalgene polypropylene straight-sided jars.
2|
Close the lid of the jars to avoid the evaporation of acetone during sonication.
| Sonicate the cover glass rack for ~1 h in acetone more than three times. Use fresh acetone each time.
4|
Move the cover glass rack to a new jar, add 3-5% (vol/vol) APTES solution in acetone to the jar and incubate the cover glasses for 30 min in the dark. Close the lid to prevent the evaporation of acetone.
5|
Wash the cover glasses with clean acetone at least three times. Do this by preparing three fresh acetone jars and gently shaking the rack holding the cover glasses in each jar for several minutes.
| Wash individual cover glasses with deionized water and acetone.
| Dry the cover glasses with filtered N 2 .
8| Prepare a humidity chamber. Add 5-10 ml of water to an empty pipette tip box. Do not remove the tip holder insert that has a flat surface.
peG coating of cover glass • tIMInG ~4-5 h 9| Place the cover glasses onto the top of the tip holder insert.
0|
Drop 70 µl of 10% (wt/vol) PEG buffer in pH 8.6 sulfate buffer (0.5 M potassium sulfate and 50 mM sodium phosphate) on the cover glasses.
| Make 'sandwiches' of pairs of cover glasses with the PEG drops pointing inside. This will ensure a uniform surface coverage of PEG. It is important to prevent the formation of bubbles between the two cover glasses.
2|
Cover the humidity chamber with the lid of the tip box and incubate the cover glasses for 2 h inside the humidity chamber. Wrap the humidity chamber with aluminum foil to keep the cover glasses in the dark.
| Separate the sandwiched pairs of cover glasses and thoroughly wash them with clean deionized water. Store the cover glasses in deionized water at 4 °C.
4|
Before use, dry the cover glasses with filtered air or N 2 .
sample chamber preparation • tIMInG ~−2 h 5| Drill holes with diamond-point drill bits in glass slides for inlets and outlets (Fig. a) .
| Apply double-sided tape onto a clean glass slide and cut out rectangular shapes around the inlet and outlet holes (Figs. b-d ).
| Place a dried PEG-coated cover glass on the double-sided tape on the glass slide (Fig. e) . It is important to ensure that the PEG-coated side faces toward the interior of the sample chamber and that both the cover glass and glass slide are completely attached to the double-sided tape so that no water can leak from the chambers (a good seal should last for a couple of days). Up to 12 sample chambers can be accommodated with one glass slide. 
2|
Evaporate the chloroform in the glass tube by using a gentle stream of N 2 gas. Partially submerge the glass tube in a water-filled beaker in order to prevent large temperature changes.
22|
Further dry the lipid film by placing the glass tube in a vacuum desiccator for 2−12 h. Wrap the desiccator with aluminum foil.
2|
Apply 275 µl of purified syntaxin solution onto the dried lipid film in the bottom of the glass tube, resulting in a syntaxin-to-lipid ratio of 1:200 (as consistent with observations on purified synaptic vesicles 37 ), and an OG-to-lipid ratio of 9.2:1. The protein-to-lipid molar ratio can be varied from 1:200 to 1:2,000 by changing the protein concentration in the purified syntaxin solution.
24| Dissolve the lipid film with the syntaxin-containing solution from
Step 23 by vortexing it at a low speed that does not create bubbles.
? troublesHootInG 25| After the solution in the glass tube has cleared, apply vesicle buffer to the lipid-protein mixture. The volume of the added vesicle buffer should be 1.5 times the total volume of the lipid-protein mixture at Step 24. While applying vesicle buffer into the tube, rapid vortexing is necessary in order to prevent local concentration gradients.
2|
Apply 550 µl of SNAP-25 solution to the glass tube while rapidly vortexing it in order to prevent local concentration gradients. Note that the total volume of the resulting solution should be 4.5 times the total volume of the lipid-protein mixture at Step 24, the molar ratio of SNAP-25 to syntaxin should be >5, and the combined volume of vesicle buffer and SNAP-25 solution will dilute the OG such that it is at its CMC. Note that the CMC of OG is 23-25 mM.
Incubate the solution at ambient temperature for 15 min. We recommend repeating the SDS-PAGE of the vesicle solution right before using the vesicles in microscopy experiments.
It is recommended to check the vesicle size distribution with dynamic light scattering and/or cryo-EM imaging, as well as the protein number density and the proper orientation, as previously described 14 
4|
5|
Keep the dried lipid film in the glass tube in a vacuum desiccator for 2−12 h. Wrap the desiccator with aluminum foil.
| Mix purified synaptobrevin solution (152 µl) and purified synaptotagmin solution (100 µl), resulting in a 4.6:1 molar ratio, as consistent with observations on purified synaptic vesicles 37 .
| Dissolve sulforhodamine B powder into the synaptobrevin and synaptotagmin solution from
Step 36 in order to obtain a 50 mM final concentration of sulforhodamine B. Ensure that sulforhodamine B is properly dissolved by gentle mixing; if necessary, use a rotating platform at ambient temperature.
8| Apply the solution from
Step 37 to the dried lipid film resulting in a synaptobrevin-to-lipid ratio of approximately 1:200 (consistent with observations on purified synaptic vesicles 37 ), and an OG-to-lipid ratio of 8.4:1. Note that the synaptobrevinto-lipid molar ratio can be varied from 1:200 to 1:2,000 by changing the protein concentration in the purified synaptobrevin and synaptotagmin solutions.
9|
Dissolve the lipid film with protein solution by vortexing it at a low speed that does not create bubbles.
40|
Dilute the OG concentration in the lipid-protein-dye mixture (from Step 39) below the CMC. For dilution use vesicle buffer with added 50 mM sulforhodamine B; ensure that the sulforhodamine B is properly dissolved by fast vortexing. Add 3.5 times the volume of the lipid-protein-dye mixture from Step 39. At this dilution, the resulting OG concentration will be at its CMC. Rapid vortexing is necessary while applying the vesicle buffer.
4| Pass the sample solution through a CL-4B column in order to separate detergents and other impurities from the protein-lipid-detergent mixture and in order to remove free sulforhodamine B dyes that are not encapsulated in vesicles. The CL-4B column must be prewashed and pre-equilibrated with vesicle buffer before use. Vesicle buffer is used as the eluent after the sample solution has entered the stationary volume of the column.
42|
Collect the void volume eluate from the column.
4| Dialyze the collected vesicle solution from
Step 42 in a 10-kDa-MWCO dialysis cassette into 1 liter of vesicle buffer overnight at 4 °C. For 1 ml of collected vesicle solution, use 500 ml of vesicle buffer. For every 500 ml of vesicle buffer, add 0.5 g of Bio-Beads powder.  crItIcal step Use different dialysis beakers for acceptor and donor vesicles in order to avoid cross-contamination.
44|
Check the protein incorporation ratio in vesicles by SDS-PAGE gel electrophoresis and by staining the gel with Coomassie blue. Initially, load 20-50 µl of vesicle solution in the gel. If the protein bands are too faint or overloaded, adjust the volume and rerun the gel. For the expected result, see ref.
14. The synaptobrevin-to-synaptotagmin ratio should be close to 4.6:1.  crItIcal step Ensure that proteins are not degraded and that no SDS-resistant bands for oligomerized synaptotagmin are visible. Use donor vesicles within 1 − 2 d after reconstitution. We recommend repeating the SDS-PAGE of the vesicle solution right before using the vesicles in microscopy experiments.
45|
It is recommended that you check the vesicle size distribution with dynamic light scattering and cryo-EM, as well as the protein number density and proper orientation, as previously described 14 .
Immobilization of acceptor vesicles • tIMInG ~ h 4|
Manually inject an ~5 µl solution of 0.5 mg ml − 1 neutravidin in vesicle buffer into the sample chamber.  crItIcal step Do not introduce bubbles into the sample chamber when injecting the solution.
4| Incubate for 15 min at ambient temperature.
48|
Thoroughly wash the sample chamber with 100-200 µl of vesicle buffer.
49|
Manually inject ~30 µl of a mixture of acceptor vesicles (from Steps 20-32) and protein-free vesicles at a ratio of 1:4 into the sample chamber. Protein-free vesicles are prepared with the same vesicle preparation method as the acceptor vesicles, except that no proteins are present in the OG buffer. The presence of protein-free vesicles reduces the density of the acceptor vesicles on the surface; this is desirable in order to optically resolve individual vesicles.
50|
Incubate the system from Step 49 for 30 min at ambient temperature.
5|
Thoroughly wash out excess vesicles with 100-200 µl of vesicle buffer. Any soluble accessory proteins (e.g., complexin) can be added at this step if necessary. alignment of excitation/imaging paths and outlet port • tIMInG ~0 min 5| Check that the green, red and blue lasers are aligned correctly. Ensure that the individual laser beams impinge on the same area of the sample plane, that the laser beams are producing TIR at the interface between the buffer and cover glass and that the optical elements in the imaging paths are properly aligned.
Incubation of donor vesicles
5|
Place the bead-mapping sample (from in the sample stage. Image the beads using both the content and lipid dye fluorescence emission paths.
? troublesHootInG 58| Ensure that the EM-CCD camera monitoring the calcein dye fluorescence intensity is externally triggered by the other CCD camera.
? troublesHootInG 59| Align the emission paths for both content and lipid dyes. The images of both dyes should be identical.
0| Take several images of the bead sample. 2| Locate the desired sample chamber prepared from
Step 55.
| Check the syringe in the motorized pump. Ensure that there are no bubbles in the tubing.
? troublesHootInG
4|
Place an O-ring at end of the tubing onto the top of the outlet of the sample chamber and tighten the pin to obtain a good seal between the O-ring and the slide glass surface (Fig. ) .
5|
Turn on all lasers.
| Start the 'live' mode in the acquisition software (Andor Solis) to check the lipid and content dye fluorescence intensity imaging channels and the focus.
| Adjust neutral density (ND) filters to reduce photobleaching. ca 2 + injection • tIMInG ~2 min 8| Gently apply a 40-50-µl drop of vesicle buffer (including the same soluble proteins used at Steps 51 and 52 at their respective concentrations) on the top of the inlet hole and draw the buffer into the sample chamber using the motorized syringe connected to the outlet hole (Fig. g) | Identify vesicles in both content and lipid dye channels by finding fluorescent spots with peaks well above the background in the 'sif' movie files using the custom IDL program. Load a movie file into TIR 2007 by clicking the 'load' button ( Fig. ) .
4|
Register the spots in both channels by applying the 2D polynomial mapping produced by Step 61. If the fluorescence intensity of the spot is too weak in one of the channels, use the position predicted from the transformation instead. First, load the mapping coefficient by clicking the 'load mapping coefficient' button. Start the movie by clicking the arrow button on the window and stop the movie after Ca 2 + injection. Next, click the 'find peaks' button to select spots in the field of view.
5|
Generate fluorescence intensity time traces for each spot in both channels by integrating a fixed number of pixels around each spot. The pixels to be integrated are centered at the centroid of the spot. Click the button with a tooltip that reads 'Calculate full traces' . The calculated fluorescence intensity time traces of an individual spot will show up on the upper right-hand side panel ( Fig. ) .
| For each spot, visually identify and record fluorescence intensity jumps in both content and lipid dye fluorescence intensity time traces using the custom IDL program. First, load the trace into the 'Fusion09' program (Fig. 8) . Second, navigate through individual traces via the 'previous', 'next', 'jumpto' buttons. Third, use the 'accept' and 'reject' buttons to reject traces containing no information. Fourth, double-click a trace plot in order to activate or deactivate the particular trace plot of a channel. Finally, when a channel is activated, press 'ctrl' while left-clicking where an intensity jump occurs in order to record such an event. You should only accept jumps that are larger than the average noise level of the trace before and after the 8| Export recorded events (i.e., fluorescence intensity jumps) from the 'Fusion09' program as a .csv file. Each line of the csv file contains the recorded events from a particular fluorescence intensity time trace. The comma-separated line begins with the content ID followed by the time points of the recorded events and followed by the acceptor lipid ID and the time points from the acceptor trace. Note that there are six fields for each channel reserved for recorded jumps, and an empty field indicates that there were no more jumps identified. We expect at most one jump event per trace for most of the traces.
9|
Define time '0' as the time bin when the blue fluorescence intensity jump occurs. Generate histograms of content-and lipid-mixing events using the time binning chosen for the experiment.
80|
Fit single or double exponential decay functions to the histograms using programs such as IGOR Pro (Wavemetrics) or ORIGIN (OriginLab). Extract time constants and amplitudes of each population.
8|
Load an image of a bead sample (Fig. 9a) .
82|
To select three desired bead pairs from the loaded image, click 'InterAct' in the window of the 'BeadMapping' program. Locate the cursor on the top of a bead and click; a square will be positioned on the bead.
8|
Locate the bead on the center of the square by using the arrow buttons on the keyboard for the content channel on the left side. To register both channels, find the matching bead and locate the second square on the top of it. Holding the 'ctrl' key while using arrow buttons will allow you to move the second square for the lipid channel. 84| When one pair of beads is identified by the two squares, press the space bar.
85|
Find and register two more pairs of beads that are noncollinear and separated as much as possible in the given field of view (Fig. 9b). 8| Click on the 'mapping' button on the window. The mapping coefficient (xx.coe) will then be automatically saved in the directory folder that contains the bead image (Fig. 9c) .
? troublesHootInG Troubleshooting advice can be found in table 2.
• tIMInG 
antIcIpateD results
Before Ca 2 + injection, the content and lipid dye fluorescence intensities for each observed spot are expected to be relatively constant. After Ca 2 + injection, statistically significant jumps in lipid and content dye fluorescence intensities are expected to occur at certain times for each spot depending on the experimental conditions and factors included in the system (Fig. 4, Step 76). The fluorescence intensities should be relatively constant before and after each jump, although slow gradual drifts are sometimes observed because of photobleaching, as also mentioned in the Introduction. The fluorescence intensity jumps can be used to classify events into immediate fusion, delayed fusion or hemifusion of individual vesicle pairs. We define 'immediate' fusion as a jump in content dye fluorescence intensity at the instance of Ca 2 + injection, and 'delayed' fusion as a content dye fluorescence intensity jump at some later time after Ca 2 + injection; in both cases, the content dye fluorescence intensity jump is generally associated with a lipid dye fluorescence intensity jump, although there may be a few cases when the lipid dye fluorescence intensity jump is small as a result of noise or prior photobleaching. Hemifusion is characterized by a lipid dye fluorescence intensity jump without a corresponding content dye fluorescence intensity jump (Fig. 4c) . Vesicle leakage can be easily distinguished from genuine fusion events, as they lead to a small rapid increase, followed by a rapid complete decay of content dye fluorescence intensity 14 . Typically, hundreds to thousands of time traces should be analyzed in order to obtain statistically significant histograms (Fig. 0) . Some Ca 2 + -triggered fusion was observed with SNAREs and synaptotagmin 1 in the absence of complexin 14 . When complexin was added to the system during both the incubation and the observation periods, Ca 2 + -triggered fusion was enhanced 14 . Immediate fusion was much more enhanced by complexin at a lower (250 µM) Ca 2 + concentration 18 . We are currently exploring the effects of other factors, such as Munc18 and Munc13, on our system. 
